Historical Valuation
Zimmer Biomet Holdings Inc (ZBH) is now in the Undervalued zone, suggesting that its current forward PE ratio of 10.73 is considered Undervalued compared with the five-year average of 15.80. The fair price of Zimmer Biomet Holdings Inc (ZBH) is between 175.13 to 215.87 according to relative valuation methord. Compared to the current price of 94.08 USD , Zimmer Biomet Holdings Inc is Undervalued By 46.28%.
Relative Value
Fair Zone
175.13-215.87
Current Price：94.08
46.28%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Zimmer Biomet Holdings Inc (ZBH) has a current Price-to-Book (P/B) ratio of 1.40. Compared to its 3-year average P/B ratio of 1.85 , the current P/B ratio is approximately -24.53% higher. Relative to its 5-year average P/B ratio of 2.02, the current P/B ratio is about -30.84% higher. Zimmer Biomet Holdings Inc (ZBH) has a Forward Free Cash Flow (FCF) yield of approximately 6.76%. Compared to its 3-year average FCF yield of 4.40%, the current FCF yield is approximately 53.71% lower. Relative to its 5-year average FCF yield of 4.08% , the current FCF yield is about 65.75% lower.
P/B
Median3y
1.85
Median5y
2.02
FCF Yield
Median3y
4.40
Median5y
4.08
Competitors Valuation Multiple
AI Analysis for ZBH
The average P/S ratio for ZBH competitors is 4.61, providing a benchmark for relative valuation. Zimmer Biomet Holdings Inc Corp (ZBH.N) exhibits a P/S ratio of 2.09, which is -54.77% above the industry average. Given its robust revenue growth of 9.71%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for ZBH
1Y
3Y
5Y
Market capitalization of ZBH increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of ZBH in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is ZBH currently overvalued or undervalued?
Zimmer Biomet Holdings Inc (ZBH) is now in the Undervalued zone, suggesting that its current forward PE ratio of 10.73 is considered Undervalued compared with the five-year average of 15.80. The fair price of Zimmer Biomet Holdings Inc (ZBH) is between 175.13 to 215.87 according to relative valuation methord. Compared to the current price of 94.08 USD , Zimmer Biomet Holdings Inc is Undervalued By 46.28% .
What is Zimmer Biomet Holdings Inc (ZBH) fair value?
ZBH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Zimmer Biomet Holdings Inc (ZBH) is between 175.13 to 215.87 according to relative valuation methord.
How does ZBH's valuation metrics compare to the industry average?
The average P/S ratio for ZBH's competitors is 4.61, providing a benchmark for relative valuation. Zimmer Biomet Holdings Inc Corp (ZBH) exhibits a P/S ratio of 2.09, which is -54.77% above the industry average. Given its robust revenue growth of 9.71%, this premium appears unsustainable.
What is the current P/B ratio for Zimmer Biomet Holdings Inc (ZBH) as of Jan 09 2026?
As of Jan 09 2026, Zimmer Biomet Holdings Inc (ZBH) has a P/B ratio of 1.40. This indicates that the market values ZBH at 1.40 times its book value.
What is the current FCF Yield for Zimmer Biomet Holdings Inc (ZBH) as of Jan 09 2026?
As of Jan 09 2026, Zimmer Biomet Holdings Inc (ZBH) has a FCF Yield of 6.76%. This means that for every dollar of Zimmer Biomet Holdings Inc’s market capitalization, the company generates 6.76 cents in free cash flow.
What is the current Forward P/E ratio for Zimmer Biomet Holdings Inc (ZBH) as of Jan 09 2026?
As of Jan 09 2026, Zimmer Biomet Holdings Inc (ZBH) has a Forward P/E ratio of 10.73. This means the market is willing to pay $10.73 for every dollar of Zimmer Biomet Holdings Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Zimmer Biomet Holdings Inc (ZBH) as of Jan 09 2026?
As of Jan 09 2026, Zimmer Biomet Holdings Inc (ZBH) has a Forward P/S ratio of 2.09. This means the market is valuing ZBH at $2.09 for every dollar of expected revenue over the next 12 months.